COMP <GO>
ZBH vs ALGN // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Zimmer Biomet Holdings Inc. (NYSE) VS. Align Technology Inc. (NASDAQ) • 15-METRIC TALLY: ZBH 8
— ALGN 6
■ METRIC PARITY
LAST: $97.35 (+2.99%) • MKT CAP: $18.03B
options-implied-move
—
LAST: $154.13 (+2.83%) • MKT CAP: $10.65B
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZBH VS. ALGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZBH | ALGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 69.70% | 67.20% | +2.50 | ZBH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.60% | 11.10% | -6.50 | ALGN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 19.3x | 17.0x | +2.30 | ALGN | /valuation <GO> |
| Free Cash Flow Yield | 7.92% | 4.49% | +3.43 | ZBH | /fcf-yield <GO> |
| Operating Margin | 13.30% | 13.50% | -0.20 | ALGN | /operating-margins <GO> |
| Net Profit Margin | 8.60% | 10.20% | -1.60 | ALGN | /net-margins <GO> |
| Revenue Growth (YoY) | 7.20% | 0.90% | +6.30 | ZBH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.02% | 0.00% | +1.02 | ZBH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.42 | 4.62 | -2.20 | ALGN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ZBH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 48.8 | 49.0 | -0.20 | ALGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.90 | +0.12 | ZBH | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.6x | 24.7x | -0.10 | ZBH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $18.03B | $10.65B | $7.38B | ZBH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZBH REV | ALGN REV | ZBH GROSS % | ALGN GROSS % | ZBH FCF | ALGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.23B | $4.03B | 69.7% | 67.2% | $1.47B | $490.8M |
| FY 2024 | $7.68B | $4.00B | 71.5% | 70.0% | $1.30B | $622.7M |
| FY 2023 | $7.39B | $3.86B | — | — | $1.25B | $612.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZBH // BETA 1.02
ALGN // BETA 0.90